Immunotherapy Versus Chemotherapy for Methotrexate-Resistant Low-Risk Gestational Trophoblastic Neoplasia

被引：8
|
作者：
Lurain, John R. [1 ]
Schink, Julian C. [2 ]
机构：
[1] Northwestern Univ, Feinberg Sch Med, Brewer Trophoblast Dis Ctr, Chicago, IL 60611 USA
[2] Canc Treatment Ctr Amer, Zion, IL 60099 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 36期
关键词：
D O I：
10.1200/JCO.20.02613
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：4349 / +
页数：3
相关论文
共 50 条
  • [1] Immunotherapy Versus Chemotherapy for Methotrexate-Resistant Low-Risk Gestational Trophoblastic Neoplasia Reply
    You, Benoit
    Bolze, Pierre-Adrien
    Golfier, Francois
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (36) : 4350 - +
  • [2] Actinomycin-D for methotrexate-resistant low-risk gestational trophoblastic neoplasia (GTN)
    Lurain, J.
    Schink, J.
    [J]. GYNECOLOGIC ONCOLOGY, 2012, 125 : S67 - S67
  • [3] Effectiveness and toxicity of second-line actinomycin D in patients with methotrexate-resistant postmolar low-risk gestational trophoblastic neoplasia
    Maesta, Izildinha
    Nitecki, Roni
    Freitas Desmarais, Cecilia Canedo
    Horowitz, Neil S.
    Goldstein, Donald P.
    Elias, Kevin M.
    Berkowitz, Ross S.
    [J]. GYNECOLOGIC ONCOLOGY, 2020, 157 (02) : 372 - 378
  • [4] Weekly intramuscular methotrexate in the treatment of low-risk gestational trophoblastic neoplasia
    Mitra Mohit
    Zahra Sarraf
    Gelavizh Sheikhi
    Minoo Robati
    Amir Vasheghani-Farahani
    [J]. Archives of Gynecology and Obstetrics, 2009, 280 : 775 - 780
  • [5] Outcome of low-risk gestational trophoblastic neoplasia (GTN) treated with methotrexate
    Ahmeed, S.
    [J]. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2014, 121 : 202 - 202
  • [6] Weekly intramuscular methotrexate in the treatment of low-risk gestational trophoblastic neoplasia
    Mohit, Mitra
    Sarraf, Zahra
    Sheikhi, Gelavizh
    Robati, Minoo
    Vasheghani-Farahani, Amir
    [J]. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2009, 280 (05) : 775 - 780
  • [7] OUTCOME OF LOW-RISK GESTATIONAL TROPHOBLASTIC NEOPLASIA (GTN) TREATED WITH METHOTREXATE
    Alobaid, A.
    Ahmeed, S.
    Saleh, R.
    Mattar, R.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [8] Eight days versus weekly intramuscular methotrexate for the treatment of low-risk gestational trophoblastic neoplasia
    Anfinan, N. M.
    Al Khatieb, M. T.
    Sait, H. K.
    Sait, M. K.
    Baghlaf, O. A.
    Mousa, A. A.
    Sait, K. H.
    [J]. EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2020, 41 (02) : 227 - 232
  • [9] Pulse methotrexate versus pulse actinomycin D in the treatment of low-risk gestational trophoblastic neoplasia
    Yarandi, Fariba
    Eftekhar, Zahra
    Shojaei, Hadi
    Kanani, Soheyla
    Sharifi, Ali
    Hanjani, Parviz
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2008, 103 (01) : 33 - 37
  • [10] ABCB1 and SLCO1B1 gene polymorphisms predict methotrexate-resistant for low-risk gestational trophoblastic neoplasia
    Srisuttayasathien, Manasawee
    Areepium, Nutthada
    Lertkhachonsuk, Ruangsak
    [J]. PERSONALIZED MEDICINE, 2021, 18 (02) : 107 - 114
12345